65-6b02. Same; use in treatment by physician, limitations on interference with. No medical care facility or other health care facility shall interfere with the physician-patient relationship by restricting or prohibiting the use of amygdalin (laetrile) as an adjunct to recognized, customary or accepted modes of therapy or by itself in the treatment of any malignancy, disease, illness or physical condition when amygdalin (laetrile) is prescribed or administered by a physician, and the patient has signed the written informed request therefor substantially as set forth in K.S.A. 65-6b05.
History: L. 1978, ch. 239, ยง 2; July 1.
Structure Kansas Statutes
Article 6b - Amygdalin (laetrile)
65-6b01 Amygdalin (laetrile); definitions.
65-6b02 Same; use in treatment by physician, limitations on interference with.
65-6b03 Same; when prescribed or administered.
65-6b04 Same; act not endorsement; certain treatment by physician not prohibited.
65-6b05 Same; written informed request.
65-6b08 Same; penalty for violations of act.
65-6b10 Same; amygdalin (laetrile) enforcement fee fund.